MediView XR, Inc., a trailblazer in augmented reality (AR) surgical navigation, announced the successful closure of a $24 million Series A funding round. The round was led by industry giants including GE HealthCare, alongside esteemed healthcare institutions such as Mayo Clinic and Cleveland Clinic, with additional strategic investments from Edge Ventures, Emplify Health’s investment arm, and the JobsOhio Growth Capital Fund.
Founded on pioneering intellectual property originating at Cleveland Clinic, MediView is redefining how surgeons engage with medical imaging through its FDA-cleared XR90 platform. This revolutionary system grants clinicians “X-ray vision,” enabling them to visualize a patient’s internal anatomy in immersive 3D directly overlaid onto their body during procedures. By seamlessly merging 3D CT scans with live ultrasound, surgeons gain unprecedented accuracy, safety, and workflow efficiency in minimally invasive interventions.
“Our vision is clear: to simplify surgical navigation by equipping clinicians with intuitive, real-time 3D visualization that informs precise decision-making,” said Mina Fahim, CEO of MediView. “Partnering with GE HealthCare, Cleveland Clinic, and Mayo Clinic accelerates our journey to bring this transformative technology into operating rooms worldwide, ultimately elevating patient care.”
This capital injection will empower MediView to expand clinical adoption, deepen collaborations with imaging and therapeutic device manufacturers, and enhance its product portfolio. As augmented reality and artificial intelligence converge, the company aims to pioneer a new surgical standard—one where the cognitive load on physicians is reduced, and procedural precision is heightened.
Editorial Insight: Charting the Future of Surgical Innovation
MediView stands at the forefront of a medical technology revolution, where augmented reality transcends novelty to become an indispensable clinical tool. The integration of AR with real-time imaging is poised to dissolve longstanding barriers in surgical precision, particularly for complex, image-guided procedures like biopsies and tumor ablations.
In an era where minimally invasive techniques are not just preferred but essential for patient recovery and healthcare efficiency, MediView is driving meaningful progress. Their platform addresses critical challenges: reducing surgeon cognitive strain, improving ergonomics by enabling “heads-up” navigation, and fostering remote collaboration—all pivotal in advancing global healthcare access and quality.
Moreover, the strategic backing from renowned institutions like GE HealthCare and leading medical centers reflects strong confidence in MediView’s approach and leadership. As artificial intelligence continues to augment this technology, the potential for faster, safer, and more efficient surgeries becomes a tangible reality—heralding a paradigm shift in patient outcomes and clinical workflows.
By championing precision, collaboration, and innovation, MediView is not only creating a new standard for surgical navigation but also illuminating a path toward a future where technology and medicine converge seamlessly for the benefit of all.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
